Hua‐Zhen Xu

A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin

Xiaoxin Yang, Xiang Xu, Meifang Wang et al. · Journal of Nanobiotechnology · 2022 · 78 citations · Full text

Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy

Ning Han, Ziyi Yang, Zhong-Xiong Xie et al. · Phytomedicine · 2023 · 78 citations

Ferroptosis-triggered Er Stress, Dna Damage, Oncogenic Agent +9

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer

Shen-Jun Yuan, Yong‐Hong Xu, Chao Wang et al. · Journal of Nanobiotechnology · 2019 · 75 citations · Full text

Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage

Liu‐Gen Li, Xing‐Chun Peng, Tingting Yu et al. · Frontiers in Pharmacology · 2022 · 69 citations · Full text

A Dihydroartemisinin‐Loaded Nanoreactor Motivates Anti‐Cancer Immunotherapy by Synergy‐Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage

Liu‐Gen Li, Xiaoxin Yang, Hua‐Zhen Xu et al. · Advanced Healthcare Materials · 2023 · 68 citations

Nanoparticles, M2 Phenotype, Nanotherapeutics +22